Related references
Note: Only part of the references are listed.Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives
Rajesh K. Singh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma
Chatla Srinivas et al.
APOPTOSIS (2016)
Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects
Katarzyna Krukiewicz et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes
Gopikrishna Moku et al.
BIOMATERIALS SCIENCE (2016)
Panobinostat for the Treatment of Multiple Myeloma
Jacob P. Laubach et al.
CLINICAL CANCER RESEARCH (2015)
Examples of Tumor Growth Inhibition Properties of Liposomal Formulations of pH-Sensitive Histidinylated Cationic Amphiphiles
Arup Garu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Examples of Tumor Growth Inhibition Properties of Liposomal Formulations of pH-Sensitive Histidinylated Cationic Amphiphiles
Arup Garu et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2015)
Clinical Nanomedicine: A Solution to the Chemotherapy Conundrum in Pediatric Leukemia Therapy
V. Krishnan et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma
A. Newbold et al.
ONCOGENE (2014)
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
NudC Deacetylation Regulates Mitotic Progression
Carol Chuang et al.
PLOS ONE (2013)
Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells
Huitao Fan et al.
EPIGENETICS (2012)
Apoptosis Induction by SAHA in Cutaneous T-Cell Lymphoma Cells Is Related to Downregulation of c-FLIP and Enhanced TRAIL Signaling
Nadya Al-Yacoub et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
Paul A. Marks
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma
Magdalena B. Wozniak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Histone deacetylase inhibitor-induced sensitization to TNFα/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression
Katalin Darvas et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Cytotoxicity Mediated by Histone Deacetylase Inhibitors in Cancer Cells: Mechanisms and Potential Clinical Implications
David S. Schrump
CLINICAL CANCER RESEARCH (2009)
Bcl-2-family proteins and hematologic malignancies: history and future prospects
John C. Reed
BLOOD (2008)
A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
Thehang H. Luu et al.
CLINICAL CANCER RESEARCH (2008)
Caspases in apoptosis and beyond
J. Li et al.
ONCOGENE (2008)
Histone deacetylases and cancer
M. A. Glozak et al.
ONCOGENE (2007)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells
LK Gediya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Protein posttranslational modifications: The chemistry of proteome diversifications
CT Walsh et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl
RJ Anto et al.
CARCINOGENESIS (2002)
Share Paper
